Key Insights

Highlights

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07466784Recruiting

CEDRN: Opioid Registry

NCT01881802UnknownPrimary

Study of Opioid Immunosuppressive Effects

Showing all 2 trials

Research Network

Active Sponsors

  • Canadian Institutes of Health Research (CIHR)1
  • University of British Columbia1
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Top Investigators

Related Conditions

  • Polysubstance Abuse1
  • Polysubstance Drug Use Indiscriminate Drug Use1
  • Opioid Use Disorder1
  • Opioid Withdrawal1

Activity Timeline